Quantitation of Urinary Somatomedin-C and Growth Hormone in Preterm and Fullterm Infants and Normal Children

Publisher Website
Google Scholar
Abstract
Urinary GH and somatomedin-C/insulin-like growth factor I (Sm-C/IGF-I) excretion were measured in 12-h urine collections obtained from 43 infants (27 stable preterm infants and 16 healthy fullterm infants) and 31 normal children, aged 3–17 yr. Urinary Sm-C/IGF-I was excreted as the free hormone, since no binding of radiolabeled Sm-C/IGF-I to any urine protein with a mol wt similar to those described for plasma Sm-C/IGF-I-binding proteins was found. The preterm infants excreted significantly more urinary GH [13.5 ± 2.1 (±SE) ng/kg·12 h] than either the fullterm infants (5.3 ± 1.6 ng/kg·12h) or the children (0.27 ± 0.02 ng/kg·12 h; P < 0.01). The mean urinary Sm-C/IGF-I excretion in the preterm infants (98.9 ± 7.5 mU/kg·12 h) was comparable to that in fullterm infants (87.6 ± 9.7 mU/kg·12 h); both groups excreted significantly more urinary Sm-C/IGF-I than children (28.4 ± 2.1 mU/kg·12 h; P < 0.01). The group differences were similar when the results were expressed in terms of creatinine excretion. Urinary GH excretion correlated positively with urinary Sm-C/IGF-I excretion (r = 0.68). The higher output of these peptides in rapidly growing infants and their positive correlation in urine provide additional support for the Sm hypothesis.